A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
Clinical trial NCT01774747 · TERMINATED
Trial details
- NCT number
- NCT01774747
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-04-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.